Your session is about to expire
← Back to Search
Virus Testing
Saliva test kit for Coronavirus
N/A
Waitlist Available
Led By Manisha Desai, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 days per participant
Awards & highlights
Study Summary
This trial will help determine if a saliva-based test can be used to monitor for SARS-CoV-2 infection at home.
Eligible Conditions
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 days per participant
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 days per participant
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Matched Test Colormetric Interpretation as a Measure of Interrater Reliability
Number of Positive Home Saliva Tests as Determined by the Patient
Secondary outcome measures
Number of Participants That Called Technical Support
Participant-rated Confidence in Interpreting Results
Participant-rated Ease of Use
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Saliva testExperimental Treatment1 Intervention
Participants perform each test assay, noting the results for comparison by technician, and completing survey questionnaires.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Saliva test kit
2020
N/A
~1280
Find a Location
Who is running the clinical trial?
BIOBOXUNKNOWN
Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,342,175 Total Patients Enrolled
Manisha Desai, PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
122 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger